BCL2 and neoplasm: In this tumor, negative modulation of the CDX2/miR-615-5p/IGF2 axis was associated with increased tumor size and weight in animal models, as well as increased expression of tumor progression markers such as Ki-67, cyclin D1, c-MYC and Bcl-2 [57].